Operating income
Flow – sum over the period · $M
Q4 2024
0.1a$M
derived
All values (14)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 89.2 | reported |
| Q1 2026 | 61.8 | reported |
| Q4 2025 | 67.0 | derived |
| Q3 2025 | 55.4 | reported |
| Q2 2025 | 39.8 | reported |
| Q1 2025 | 11.3 | reported |
| Q4 2024 | 0.1 | derived |
| Q3 2024 | −8.9 | reported |
| Q2 2024 | −24.3 | reported |
| Q1 2024 | −83.0 | reported |
| Q4 2023 | 9.0 | derived |
| Q3 2023 | −2.0 | reported |
| Q2 2023 | −17.6 | reported |
| Q1 2023 | −18.9 | reported |
28 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: operating_income
More metrics for Astera Labs
Income statement
Balance sheet
Revenue by segment/product/region
Sources & calculation
- Value
- 144,000 USD (derived)
- Period
- Q4 2024, ended Dec 31, 2024 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = −116M − −116M = $0.00 (FY value from 10-K 0001736297-26-000010; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Feb 20, 2026 · 0001736297-26-000010
- Location
- us-gaap:OperatingIncomeLoss
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | 144,000 USD | Feb 20, 2026 | 10-K 0001736297-26-000010 | derived · confidence 1. · current |